Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide (Q45078360)

9 December 2017

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide (English)

1 reference

9 December 2017

8

1 reference

9 December 2017

Hideaki Kaneto

1

1 reference

9 December 2017

Yoshihisa Nakatani

2

1 reference

9 December 2017

Takeshi Miyatsuka

3

1 reference

9 December 2017

Dan Kawamori

4

1 reference

9 December 2017

Taka-aki Matsuoka

5

1 reference

9 December 2017

Munehide Matsuhisa

6

1 reference

9 December 2017

Yoshitaka Kajimoto

7

1 reference

9 December 2017

Yoshimitsu Yamasaki

9

1 reference

9 December 2017

Masatsugu Hori

10

1 reference

9 December 2017

language of work or name

English

0 references

publication date

26 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

10

1 reference

9 December 2017

1128-1132

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1111

9 December 2017

0 references

cites work

Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain

1 reference

7 January 2021

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

1 reference

7 January 2021

Signal transduction by the JNK group of MAP kinases

1 reference

7 January 2021

Mammalian MAP kinase signalling cascades

1 reference

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

7 January 2021

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

1 reference

7 January 2021

Targeting JNK for therapeutic benefit: from junk to gold?

1 reference

7 January 2021

Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression

1 reference

7 January 2021

Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase.

1 reference

7 January 2021

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

7 January 2021

Intercellular trafficking and protein delivery by a herpesvirus structural protein

1 reference

7 January 2021

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

7 January 2021

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration

1 reference

7 January 2021

Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation

1 reference

7 January 2021

PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells

1 reference

7 January 2021

A new cell-permeable peptide allows successful allogeneic islet transplantation in mice

1 reference

7 January 2021

Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death

1 reference

7 January 2021

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways

1 reference

7 January 2021

ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis

1 reference

7 January 2021

Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide

1 reference

7 January 2021

Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells

1 reference

7 January 2021

The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells

1 reference

7 January 2021

IB1 reduces cytokine-induced apoptosis of insulin-secreting cells

1 reference

7 January 2021

beta-cell apoptosis: stimuli and signaling

1 reference

7 January 2021

The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1111

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference